Novavax Stock Price on October 11, 2024
| NVAX Stock | USD 8.62 0.13 1.49% |
Below is the normalized historical share price chart for Novavax extending back to December 05, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novavax stands at 8.62, as last reported on the 28th of November, with the highest price reaching 9.03 and the lowest price hitting 8.55 during the day.
If you're considering investing in Novavax Stock, it is important to understand the factors that can impact its price. Novavax has Sharpe Ratio of -0.0752, which conveys that the firm had a -0.0752% return per unit of risk over the last 3 months. Novavax exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novavax's Risk Adjusted Performance of (0.02), mean deviation of 3.77, and Standard Deviation of 5.58 to check out the risk estimate we provide.
At this time, Novavax's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.9 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (681.1 M). . Price Earnings To Growth Ratio is likely to rise to 0.03 in 2024, whereas Price To Sales Ratio is likely to drop 0.47 in 2024. Novavax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of December 1995 | 200 Day MA 10.1807 | 50 Day MA 10.6442 | Beta 2.088 |
Novavax |
Sharpe Ratio = -0.0752
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVAX |
Estimated Market Risk
| 5.59 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novavax is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novavax by adding Novavax to a well-diversified portfolio.
Price Book 49.522 | Enterprise Value Ebitda (0.53) | Price Sales 1.5599 | Shares Float 143.4 M | Wall Street Target Price 16 |
Related Headline
Vaxart Headline on 11th of October 2024
Filed transaction by Vaxart Inc Officer Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Novavax Valuation on October 11, 2024
It is possible to determine the worth of Novavax on a given historical date. On October 11, 2024 Novavax was worth 12.72 at the beginning of the trading date compared to the closed value of 12.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novavax stock. Still, in general, we apply an absolute valuation method to find Novavax's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novavax where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novavax's related companies.
| Open | High | Low | Close | Volume | |
| 12.60 | 13.33 | 12.60 | 12.91 | 4,462,532 | |
10/11/2024 | 12.72 | 13.04 | 12.34 | 12.53 | 5,767,285 |
| 12.43 | 13.34 | 12.23 | 12.62 | 5,635,240 |
| Backtest Novavax | | | Novavax History | | | Novavax Valuation | Previous | Next |
Novavax Trading Date Momentum on October 11, 2024
| On October 14 2024 Novavax was traded for 12.62 at the closing time. The top price for the day was 13.34 and the lowest listed price was 12.23 . The trading volume for the day was 5.6 M. The trading history from October 14, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.72% . The trading delta at closing time against the current closing price is 19.39% . |
Novavax Fundamentals Correlations and Trends
By evaluating Novavax's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novavax's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novavax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novavax Stock history
Novavax investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novavax will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novavax stock prices may prove useful in developing a viable investing in Novavax
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 100.8 M | 105.8 M | |
| Net Loss | -592.1 M | -562.5 M |
Novavax Stock Technical Analysis
Novavax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novavax Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Novavax cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novavax November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Novavax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novavax shares will generate the highest return on investment. By undertsting and applying Novavax stock market strength indicators, traders can identify Novavax entry and exit signals to maximize returns
Novavax Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novavax's price direction in advance. Along with the technical and fundamental analysis of Novavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.